Australia's PBS spend "under control"

5 April 2009

A new report by Access Economics confirms spending on the Pharmaceutical Benefits Scheme operated in Australia will not spiral out of control, as  the former John Howard government's two intergenerational reports  predicted. The new study was presented on April 2.

Pharmaceutical body Medicines Australia's chief executive, Ian  Chalmers, said the report demonstrates very clearly that the PBS will be  sustainable into the future and will not blow out government health care  budgets.

"This important study presents a powerful argument to the Rudd  government as to why the PBS should be quarantined from budget cuts,"  Mr Chalmers noted. "We now have compelling independent evidence that  growth is being contained and we have a sustainable PBS," he said.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight